The origin of postmenopausal oestrogens

European Journal of Cancer

Volumn 38, Issue SUPPL. 6, 2002, Pages

  Neven, P ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; ESTRONE; PRASTERONE SULFATE;

ARTICLE; BLOOD SAMPLING; BODY MASS; BREAST CANCER; DIET RESTRICTION; ENDOMETRIUM CANCER; HEALTH STATUS; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; POSTMENOPAUSE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

AROMATASE; BONE DENSITY; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; POLYMORPHISM, GENETIC; POSTMENOPAUSE;

EID: 0036753586     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)80026-0     Document Type: Article

References (17)

1. Zmuda J.M., Cauley J.A., Ljung B.M.et al. Bone mass and breast cancer risk in older women. differences by stage at diagnosis J Natl Cancer Inst. 93:2001;930-936.
2. Hankinson S.E., Willett W.C., Manson J.E.et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 90:1998;1292-1299.
3. Zeleniuch-Jacquotte A., Akhmendkhanov A., Kato I.et al. Postmenopausal endogenous oestrogens and risk of endometrial cancer. results of a prospective study Brit J Cancer. 84:2001;975-981.
4. Speroff L. Hormone biosynthesis, metabolism and mechanism of action. In Speroff L, Glass RH, Kase NG, eds. Clinical Gynecologic Endocrinology and Infertility. New York, Lippincott Williams & Wilkins, 1999, 31-105.
5. Couzinet B., Meduri G., Lecce M.G.et al. The postmenopausal ovary is not a major androgen-producing gland. J Clin Endocrinol Metab. 86:2001;5060-5065. 066.
6. Kaye S.A., Folsom A.R., Soler J.T.et al. Association of body mass and fat distribution with sex hormone concentrations in postmenopausal women. Int J Epidemiol. 20:1991;151-156.
7. Miyoshi Y., Ando A., Shiba E.et al. Involvement of up-regulation of l7beta-hydroxysteroid dehydrogenase type I in maintenance of intratumoral high estradiol levels in postmenopausal breast cancers. Int J Cancer. 94:2001;685-689.
8. Geisler J., Detre S., Berntsen H.et al. Influence of neoadjuvant anastrazole on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer. Clin Cancer Res. 7:2001;1230-1236.
9. Miller W.R. Biology of aromatase inhibitors. pharmacology/endocrinology within the breast Endocr-Related Cancer. 6:1999;187-195.
10. Reed M.J., Purohit A. Aromatase regulation and breast cancer. Clin Endocrinol. 54:2001;563-571.
11. Zhou J., Gurates B., Yang S., Sebastian S., Bulun S.E. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta. Cancer Res. 61:2001;2328-2334.
12. Wu F., Ames R., Evans M.C., France J.T., Reid I.R. Determinants of sex hormone-binding globulin in normal postmenopausal women. Clin Endocrinol (Oxf). 54:2001;81-87.
13. Thompson P.A., Ambrosone C. Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. J Natl Cancer Inst Monogr. 27:2000;125-134.
14. Haiman C.A., Hankinson S.E., Spiegelman D. The relationship between a polymorphism in CYP 17 with plasma hormone levels and breast cancer. Cancer Res. 59:1999;1015-1020.
15. Haiman C.A., Hankinson S.E., Colditz G.A. A polymorphism in CYPI7 and endometrial cancer risk. Cancer Res. 61:2001;3955-3960.
16. Holmes P., Harrison P.T.C. Environmental and dietary endocrine disruptors and women's health. J Br Menopause Soc. 7:2001;53-59.
17. Singletary K.W., Gapstur S.M. Alcohol and breast cancer. review of epidemiologic and experimental evidence and potential mechanisms JAMA. 286:2001;2143-2151.